LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., the Digital Biology™ Company, today announced that it is collaborating with the Hôpital Saint-Louis in Paris, France and BGI in China, the world’s largest genomics institute, to discover new variants and confirm findings from a Rheumatoid Arthritis (RA) study conducted by researchers at the Hôpital Saint-Louis. The collaboration will utilize the unique capabilities of the RainDance HLASeq™ Research Screening Panel to target the human leukocyte antigen (HLA) super-locus.
